Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment

<div>Comparison of N′-formylkynurenine content of blood serum proteins in healthy controls, in RRMS patients without treatment, in RRMS patients treated with INF-beta, and in RRMS patients treated with INF-beta plus MEL. If not indicated, differences are not statistically significant.</div>

Oxidative Medicine and Cellular Longevity

fig1

Figure 1

Figure 1: Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment 